SBAC vs IRM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

SBAC

38.0
AI Score
VS
IRM Wins

IRM

54.1
AI Score

Investment Advisor Scores

SBAC

Nov 11, 2026
38score
Recommendation
AVOID NEW MONEY

IRM

Nov 11, 2026
54score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric SBAC IRM Winner
Forward P/E 20.79 54.0541 SBAC
PEG Ratio 11.5496 2.701 IRM
Revenue Growth -2.5% 13.5% IRM
Earnings Growth -0.5% 46.4% IRM
Tradestie Score 38.0/100 54.1/100 IRM
Profit Margin 34.5% 5.9% SBAC
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation AVOID NEW MONEY STRONG BUY IRM

Relative Price Performance (Last 90 Days)

SBAC 1M: +4.7% · 3M: +2.2% IRM 1M: -1.0% · 3M: -10.4%

Current Technical Phase

SBAC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 57.9 · Price: $190.29

IRM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.3 · Price: $113.41

Fundamentals Snapshot

Metric SBAC IRM
Market Cap — —
Forward P/E 24.2 40.8
Trailing P/E 20.6 72.5
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.7% 0.5%
Operating Margin 0.5% 0.2%
EPS 9.26 1.53
Dividend Yield 0.03% 0.03%

Frequently Asked Questions

Based on our detailed analysis, IRM is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.